Panmure Liberum appointed as AQSE Corporate Advisor and Broker to One Health Group Plc
We are delighted to announce that Panmure Liberum has been appointed Corporate Advisor and Broker to One Health Group Plc, the independent provider of free, high quality NHS care for patients referred through ‘Patient Choice’ for treatment in Orthopaedics, Spine, General Surgery and Gynaecology.
One Health is a team of medical consultants and experienced healthcare managers working in collaboration with the NHS to provide fast, free, local and expert care for NHS patients in orthopaedics, spinal, general surgery and gynaecology. As an NHS designated body, its values are strongly aligned with NHS values and the services provided are primarily through patients selecting One Health as their provider of care through ‘Patient Choice’ following a GP referral through the NHS e-Referral system.
One Health treats more than 13,000 new NHS patients every year and has over 100 NHS surgeons and anaesthetists providing their services to One Health patients across Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire.
One Health’s patient care is based on providing outpatient care and physiotherapy rehabilitation locally in one of 35 community-based outreach clinics, directing patients requiring surgery to one of the Company’s independent sector hospital partners when required.
Panmure Liberum Team
Investment Banking – Emma Earl, Will Goode, Mark Rogers, Joshua Borlant
Corporate Broking – Rupert Dearden, Rauf Munir
Research – Seb Jantet
Sales – David Cox
